Yuichi Takashi Kyoko Toyokawa Naoki Oda Yoshimi Muta Hisashi Yokomizo Seiji Fukumoto Daiji Kawanami
10.3389/fendo.2022.1004624
Front Endocrinol (Lausanne)
2022 Dec 2;13:1004624.
x-linked hypophosphatemia burosumab evocalcet fibroblast growth factor 23 parathyroid hormone tertiary hyperparathyroidism
CC BY
https://pubmed.ncbi.nlm.nih.gov/36531500/
Familial Hypophosphatemic Rickets / complications Familial Hypophosphatemic Rickets / drug therapy Hyperparathyroidism Hypophosphatemia / drug therapy Hypophosphatemia / etiology
Familial Hypophosphatemic Rickets / complications Familial Hypophosphatemic Rickets / drug therapy Hyperparathyroidism Hypophosphatemia / drug therapy Hypophosphatemia / etiology Case Reports Adult Fibroblast Growth Factors / metabolism Humans Parathyroid Hormone Phosphates Parathyroid Hormone burosumab Fibroblast Growth Factors Phosphates
PMC9751939
36531500
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
2022